Radiotracers for fungal infection imaging

Antonella Lupetti1, Mark G J de Boer, Paola Erba

  • 1Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, Università di Pisa,Via San Zeno 35-39, Pisa, Italy. alupetti@biomed.unipi.it

Medical Mycology
|August 28, 2010
PubMed

Insights

New radiolabeled tracers show promise for imaging invasive fungal infections in immunocompromised patients. While some agents can detect infections, further research is needed to develop more effective fungal imaging agents.

Area of Science:

  • Nuclear Medicine
  • Medical Imaging
  • Infectious Diseases

Background:

  • Invasive fungal infections pose significant morbidity and mortality risks in immunocompromised individuals.
  • Current diagnostic methods for fungal infections have limitations, delaying crucial antifungal treatment.
  • Novel imaging tracers targeting infectious agents are being explored for improved diagnosis.

Purpose of the Study:

  • To review the potential and limitations of new radiolabeled tracers for scintigraphic imaging of fungal infections.
  • To evaluate tracers like radiolabeled antimicrobial peptides, antifungals, and chitin-specific agents.
  • To assess their efficacy in distinguishing fungal infections from other conditions.

Main Methods:

  • Evaluation of (99m)Tc-labeled peptides (UBI29-41, hLF1-11) in mice models for differentiating fungal infections.
  • Clinical trial assessment of (99m)Tc-UBI29-41 for infection vs. inflammation detection.
  • Testing of (99m)Tc-fluconazole for its specificity in imaging Candida albicans infections.
  • Assessment of (123)I-chitinase and (99m)Tc-HYNIC-CBP21 for detecting both Candida albicans and Aspergillus fumigatus infections.

Main Results:

  • (99m)Tc-labeled peptides differentiated fungal infections from sterile inflammation but not bacterial infections in mice.
  • (99m)Tc-UBI29-41 showed 80% specificity and 100% sensitivity in clinical trials for distinguishing infections.
  • (99m)Tc-hLF1-11 demonstrated utility in monitoring antifungal treatment response.
  • (99m)Tc-fluconazole was specific for Candida albicans but poorly detected Aspergillus fumigatus.
  • (123)I-chitinase and (99m)Tc-HYNIC-CBP21 showed accumulation in both fungal types at later time points.

Conclusions:

  • Recent advances in radiolabeled imaging show promise for invasive fungal infections.
  • Existing tracers have limitations in specificity and detection of certain fungal species.
  • Continued development of novel tracers is essential for improved fungal infection imaging.